Finance

Beta
Lists
BIOA:NASDAQ
BIOAGE Labs Inc
$18.04
+9.67%
(+1.59) 1D
Jun 12, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOA...
Open
$16.47
High
$18.09
Low
$16.07
Mkt. cap
801.93M
Avg. vol.
398.14K
Volume
436.92K
52-wk high
$24.00
52-wk low
$4.06
EPS
-$2.40
Shares outstanding
44.45M
No. of employees
61
Open
$16.47
High
$18.09
Low
$16.07
Mkt. cap
801.93M
Avg. vol.
398.14K
Volume
436.92K
52-wk high
$24.00
52-wk low
$4.06
EPS
-$2.40
Shares outstanding
44.45M
No. of employees
61
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to BIOA in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for BIOA in the last 3 months.
Highest
Current $18.04
$62.00 (+243.68%)
Average
$42.20 (+133.92%)
Lowest
$23.00 (+27.49%)
News stories
From sources across the web
About BIOAGE Labs Inc
CEO-
Employees61
Founded2015
HeadquartersEmeryville, California, United States
SectorPharmaceutical industry
Websitebioagelabs.com
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.52 / -$0.63
+17.13%beat
Revenue / Est. (USD)
2.77M / 1.08M
+155.88%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.41M
2.05M
3.08M
2.77M
Cost of goods sold
19.84M
18.51M
24.50M
20.41M
Cost of revenue
19.84M
18.51M
24.50M
20.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.34M
6.68M
7.00M
7.74M
Operating expense
7.34M
6.68M
7.00M
7.74M
Total operating expenses
27.18M
25.19M
31.50M
28.15M
Operating income
-24.77M
-23.14M
-28.42M
-25.38M
Other non operating income
-11.00K
-42.00K
-220.00K
-107.00K
EBT including unusual items
-21.56M
-20.17M
-25.94M
-22.25M
EBT excluding unusual items
-21.56M
-20.17M
-25.94M
-22.25M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.56M
-20.17M
-25.94M
-22.25M
Net profit margin
-893.99%
-982.03%
-842.85%
-802.78%
Earnings per share
-0.60
-0.56
-0.72
-0.52
Interest and investment income
3.42M
3.16M
2.79M
3.27M
Interest expense
-201.00K
-149.00K
-92.00K
-39.00K
Net interest expenses
3.22M
3.01M
2.70M
3.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
-24.71M
-23.09M
-28.35M
-25.31M
Gain or loss from assets sale
-
-
23.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer